2 ASX shares to buy for a post-pandemic world

Here's why I would buy these ASX shares, including CSL Limited (ASX: CSL), for a post-pandemic ASX world.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The coronavirus pandemic has turned the world of investing (as well as most other worlds) upside down. Although the S&P/ASX 200 Index (ASX: XJO) and the broader markets have substantially recovered from the lows we saw in March, it's still a difficult landscape in which to choose ASX shares for one's own portfolio.

We still don't know exactly which companies will be affected by the coronavirus shutdowns, how long they will be affected for and how long it will take for things to return to 'normal'.

Despite my belief that a strong recovery will eventually come, I think it's fairly safe to say that the economy won't look quite the same as it did before the pandemic struck.

So here are 2 ASX shares that I think will make great investments in a post-pandemic world:

world economic outlook

Image Source: Getty Images

CSL Limited (ASX: CSL)

CSL is the largest company on the ASX – and for good reason. It has grown at such a rate that its shares have more than tripled in value over the past 5 years. CSL is a leader in the global blood medicine and vaccination fields. CSL has been called upon before by the Australian government to manufacture large batches of vaccines when Swine Flu was emerging as a threat a few years ago – and its services might be required again if a vaccine for COVID-19 is found.

In fact, just today it was announced that CSL is working on an immunoglobulin therapy that has the potential to help individuals who have contracted the disease. All in all, I think CSL is a winning company – rain, hail or shine.

Ramsay Health Care Limited (ASX: RHC)

Ramsay is the largest operator of private hospitals in Australia and also has a significant global presence with its operations in the UK, Indonesia and France.

This company hasn't escaped unscathed from the coronavirus crisis – suffering when the government banned all non-essential elective surgeries in preparation for the pandemic. As a result, it initiated a capital raising and suspended its dividend payments – ending a 20-year streak for the latter.

Still, I think this company has a bright post-pandemic future. As long as the coronavirus is still around, Ramsay will be playing an important role in treatment. And once we enter a post-pandemic world, the ageing demographics of our population give Ramsay a strong tailwind and should ensure its top-notch hospitals remain in strong demand for decades to come.

Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »